Skip to main content

Table 5 Estimated costs in treatment-naïve HCV patients and matched controls

From: The burden of hepatitis C in Europe from the patients’ perspective: a survey in 5 countries

  HCV Never treated Matched controls p-value
  (n = 139) (n = 139)  
  M SD M SD  
Indirect costs
 Absenteeism € 1,293.61 € 4,398.13 € 579.62 € 2,504.32 .204
Presenteeism € 5,120.80 € 7,680.29 € 3,062.29 € 5,868.47 .015
 Total indirect € 6,414.42 € 8,587.96 € 3,641.91 € 6,699.54 .011
Direct costs
 Physician visits € 488.06 € 720.02 € 288.44 € 458.58 .003
 ER visits € 47.18 € 178.64 € 39.19 € 140.43 .979
Hospitalizations € 399.05 € 1,368.76 € 179.88 € 858.29 .124
 Total direct € 934.30 € 1,873.33 € 507.50 € 1,053.43 .005
Total costs € 3,834.44 € 6,991.25 € 2,119.56 € 4,974.79 <.001
  1. Indirect costs apply only to the 65 HCV patients and 65 matched controls who report being employed. Direct and total costs apply to the entire sample. Unemployed respondents’ indirect costs are included in total costs as €0.